Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Phase 2

Completed

Conditions: Gastric Cancer
Esophageal Cancer

Interventions: Drug: carboplatin
Drug: fluorouracil
Drug: paclitaxel
Procedure: conventional surgery
Radiation: radiation therapy

First Posted Date: 2003-03-07

Last Posted Date: 2016-12-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 56

Registration Number: NCT00022139

Locations: 🇺🇸
Cancer Center of Kansas, PA - El Dorado, El Dorado, Kansas, United States
🇺🇸
Southwest Medical Center, Liberal, Kansas, United States
🇺🇸
Cancer Center of Kansas, PA - Newton, Newton, Kansas, United States

and more 32 locations

Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer
Metastatic Cancer

Interventions: Biological: cetuximab
Drug: fluorouracil
Drug: leucovorin calcium
Drug: oxaliplatin

First Posted Date: 2003-03-07

Last Posted Date: 2017-01-24

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 73

Registration Number: NCT00056030

Locations: 🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸
CCOP - Upstate Carolina, Spartanburg, South Carolina, United States
🇺🇸
Sanford Cancer Center at Sanford USD Medical Center, Sioux Falls, South Dakota, United States

and more 155 locations

Genetic Study of Familial Factors in Patients With Colon Cancer

Completed

Conditions: Colorectal Cancer

Interventions: Genetic: cytogenetic analysis
Genetic: gene mapping
Genetic: microarray analysis

First Posted Date: 2003-03-07

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 600

Registration Number: NCT00055848

Locations: 🇺🇸
Wayne Memorial Hospital, Incorporated, Goldsboro, North Carolina, United States

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer
Osteoporosis

Interventions: Dietary Supplement: calcium carbonate
Dietary Supplement: vitamin D
Other: placebo
Drug: risedronate sodium

First Posted Date: 2003-02-06

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 216

Registration Number: NCT00054418

Locations: 🇺🇸
Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center, Wilkes-Barre, Pennsylvania, United States
🇺🇸
Mason District Hospital, Havana, Illinois, United States
🇺🇸
Piedmont Hospital, Atlanta, Georgia, United States

and more 192 locations

Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction

Phase 2

Completed

Conditions: Esophageal Cancer
Gastric Cancer

Interventions: Drug: capecitabine
Drug: docetaxel

First Posted Date: 2003-02-06

Last Posted Date: 2016-12-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 46

Registration Number: NCT00054457

Locations: 🇺🇸
Associates in Womens Health, PA - North Review, Wichita, Kansas, United States
🇺🇸
Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States
🇺🇸
Cancer Center of Kansas, PA - Winfield, Winfield, Kansas, United States

and more 25 locations

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Phase 2

Completed

Conditions: Malignant Mesothelioma

Interventions: Drug: PTK787/ZK 222584

First Posted Date: 2003-02-06

Last Posted Date: 2016-07-01

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 47

Registration Number: NCT00053885

Locations: 🇺🇸
Louis A. Weiss Memorial Hospital, Chicago, Illinois, United States
🇺🇸
Fort Wayne Medical Oncology and Hematology, Incorporated, Fort Wayne, Indiana, United States
🇺🇸
CCOP - Northern Indiana CR Consortium, South Bend, Indiana, United States

and more 77 locations

Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

Phase 2

Completed

Conditions: Lymphoma

Interventions: Biological: rituximab
Drug: cladribine

First Posted Date: 2003-01-28

Last Posted Date: 2016-12-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 30

Registration Number: NCT00053027

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

Phase 2

Completed

Conditions: Leukemia
Lymphoma
Multiple Myeloma
Plasma Cell Neoplasm
Myelodysplastic Syndromes
Myeloproliferative Neoplasms

Interventions: Biological: anti-thymocyte globulin
Biological: G-CSF
Drug: busulfan
Drug: fludarabine phosphate
Drug: methotrexate
Drug: mycophenolate mofetil
Drug: tacrolimus
Procedure: allogeneic cell transplantation
Drug: allopurinol

First Posted Date: 2003-01-28

Last Posted Date: 2016-07-01

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 82

Registration Number: NCT00053196

Locations: 🇺🇸
Union Hospital Cancer Center at Union Hospital, Elkton MD, Maryland, United States
🇺🇸
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸
Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees, Voorhees, New Jersey, United States

and more 9 locations

Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer

Phase 3

Withdrawn

Conditions: Stage IV Breast Cancer
Recurrent Breast Cancer

Interventions: Drug: tamoxifen
Drug: trastuzumab

First Posted Date: 2003-01-28

Last Posted Date: 2016-07-12

Lead Sponsor: Alliance for Clinical Trials in Oncology

Registration Number: NCT00053339

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer
Osteoporosis

Interventions: Dietary Supplement: calcium carbonate
Dietary Supplement: cholecalciferol
Drug: Estrogen Antagonists
Other: placebo
Drug: risedronate sodium

First Posted Date: 2003-01-27

Last Posted Date: 2016-12-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 71

Registration Number: NCT00043069

Locations: 🇺🇸
Memorial Hospital, Carthage, Illinois, United States
🇺🇸
Mason District Hospital, Havana, Illinois, United States
🇺🇸
Perry Memorial Hospital, Princeton, Illinois, United States

and more 111 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy